In patients with rheumatoid arthritis (RA) "cholesterol-reducing therapies may be beneficial"

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1603, 2007-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guidelines on the use of anti-tumour necrosis factor (TNF) therapies in patients with rheumatoid arthritis (RA) have been updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

BMS 188667 [CTLA41g] may be beneficial in the treatment of rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Emerging therapies for rheumatoid arthritis

By Jacques Peggy   Van den Bosch Filip  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 2, 2013-06 ,pp. : 231-244

Informa Healthcare

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Zoledronic acid may provide a structural benefit in patients with early rheumatoid arthritis

By  

Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite